Published in Cancer Weekly, February 8th, 2005
Their study, published in the online journal, Breast Cancer Research, on November 29, 2004, showed the vaccine protected 86% of experimental mice against HER2/neu-associated breast cancer, even though the tumors were implanted directly into mice.
"This is an exciting strategy that seems to elicit a complete immunologic response against HER2/neu," said the study's lead author, Lawrence Lachman, PhD,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.